Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

India Clindamycin Phosphate Market By Product Type (Prescription v/s OTC), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Gel, Topical Solution, Foam, Injection, Others), By Gender (Men v/s Women), By Distribution Channel (Online v/s Offline), By Application (Acne Vulgaris, Genito-Urinary Infections, Pseudomembranous Colitis, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of skin infections is expected to drive the growth of India clindamycin phosphate market.Read More

India Carbidopa Market By Composition (Single, Combinational), By Rate of Drug Delivery (Immediate v/s Sustained Release), By Dose (10 mg, 25mg, 50 mg, 100 mg, 250 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Suspension, Others), By Distribution Channel (Online v/s Offline), By Application (Idiopathic Parkinson's Disease (Paralysis Agitans), Postencephalitic Parkinsonism, Symptomatic Parkinsonism Including (Shakiness, Stiffness, Difficulty Moving, Spasms, Poor Muscle Control, Tremors) And Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Increase in the prevalence of Parkinson’s disease is expected to drive the growth of India carbidopa market during the forecast period.Read More

India Clarithromycin Market By Application (Strep throat, Pneumonia, Skin Infections, Respiratory Infections, Lyme Disease, Helicobacter Pylori Infection, Others), By Form (Tablet, Capsule, Suspension, Others), By Route of Administration (Oral vs Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing occurrence of bacterial infections is expected to drive the growth of India clarithromycin market during the forecast period.Read More

India Ceftriaxone Market By Dose (100 mg, 200 mg, 250 mg, 500 mg and Others), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Intramuscular Injection, Intravenous Injection, Infusion, Others), By Distribution Channel (Online v/s Offline), By Application (Endocarditis, Meningitis, Pneumonia, Bone and Joint Infections, Intra-Abdominal Infections, Skin Infections, Urinary Tract Infections, Gonorrhoea, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India ceftriaxone market during the forecast period.Read More

India Cefoperazone Market By Composition (Single, Combinational), By Route of Administration (Intramuscular v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Respiratory Infections, Skin Infections, Urinary Infections, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India cefoperazone market during the forecast period.Read More

India Losartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (25 mg, 50 mg, 100 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Stroke, Diabetic Nephropathy, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Losartan market during the forecast period.Read More

India Gabapentin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Others), By Strength (100 mg, 200 mg, 300 mg, 400 mg, Others), By Distribution Channel (Online v/s Offline), By Application (Epilepsy, Neuropathic Pain, Restless Legs Syndrome (RLS), Seizures, Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing epilepsy and restless legs syndrome is expected to drive the growth of India Gabapentin market during the forecast period.Read More

India Doxycycline Market By Product Type (Doxycycline HCL, Doxycycline Hyclate, Doxycycline Calcium, Doxycycline Monohydrate), By Form (Tablet, Capsule, Injection, Solution, Syrup, Others), By Application (Intestinal Infections, Respiratory Tract Infections, Skin Infections, Genital Infections, Urinary Tract Infections, Others), By Route of Administration (Oral, Intravenous, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India doxycycline market.Read More

India Gentamycin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Eye Drops, Tablet, Capsule, Syrup, Injection, Cream, Gel, Ointment, Others), By Route of Administration (Ophthalmic, Intravenous, Topical, Oral, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infection, Urinary Tract Infection, Sepsis, Meningitis, Skin or Soft Tissue Infection, Upper Respiratory Tract Infection, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India gentamycin market.Read More

India Ornidazole Market By Composition (Single, Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Injection, Capsule, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Vaginal Infections, Urinary Tract Infections, Intestinal Infections, Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of infections is expected to drive the growth of India ornidazole market.Read More

India Olmesartan Market By Dose (10 mg, 20 mg, 40 mg, Others), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By Application (High Blood Pressure, Heart Failure, Diabetic Kidney Disease Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Olmesartan market during the forecast period.Read More

India Telmisartan Market By Indication (Hypertension, Cardiac Arrest, Stroke, Others), By Composition (Single, Combinational), By Form (Tablet, Capsule, Injection, Others), By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Distribution Channel (Online v/s Offline), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of hypertension is expected to drive the growth of India Telmisartan market during the forecast period.Read More

India Clindamycin HCL Market By Route of Administration (Oral v/s Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Bacterial Infections, Skin and Soft Tissue Infections, Respiratory Tract Infections, Lung Infections, Others), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India clindamycin HCL market.Read More

India Ciprofloxacin Market By Composition (Single v/s Combinational), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Powder, Suspension, Capsule, Tablet, Eye Drops, Ear Drop, Injection, Others), By Route of Administration (Oral, Ophthalmic, Otic, Intravenous, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Lower Respiratory Infections, Nosocomial Pneumonia, Skin structure Infections, Bone and Joint infections, Intra-abdominal Infections, Acute Sinusitis, Conjunctivitis, Acute Otitis Externa, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India ciprofloxacin market.Read More

India Sulfadiazine Market By Product Type (OTC v/s Prescription), By Route of Administration (Oral, Topical, Intravenous), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Cream, Injection, Others), By Distribution Channel (Online v/s Offline), By Application (Urinary Tract Infections, Ear Infections, Meningitis, Malaria, Toxoplasmosis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of microbial infections is expected to drive the growth of India sulfadiazine market.Read More

India Tinidazole Market By Industry (Chemical Industry v/s Pharmaceutical Industry), By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Injection, Capsule, Syrup, Others), By Route of Administration (Oral v/s Intravenous), By Distribution Channel (Online v/s Offline), By Application (Amoebiasis, Amoebic liver Abscess, Bacterial vaginosis, Giardiasis, Trichomoniasis, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of bacterial infections is expected to drive the growth of India tinidazole market.Read More

India Valsartan Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Solution, Others), By Distribution Channel (Online v/s Offline), By Application (Hypertension, Heart Failure, Myocardial Infarction, Others), By End User (Adult v/s Pediatric), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of cardiovascular diseases is expected to drive the growth of India valsartan market.Read More

India Betamethasone Market By Source (In-house v/s Contract Manufacturing Organizations), By Type (Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate), By Form (Cream, Ointment & Lotion, Injection-Solution, Spray & Foam, Others), By Route of Administration (Parenteral, Ophthalmic, Topical, Infiltration, Intra-articular/Intralesional/Intramuscular), By Distribution Channel (Online v/s Offline), By Application (Eczema, Psoriasis, Dermatitis, Others), By End User (Hospitals & Clinics v/s Homecare), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of skin diseases is expected to drive the growth of India betamethasone market.Read More

India Atorvastatin Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet v/s Capsule), By Distribution Channel (Online v/s Offline), By Application (Hypercholesterolemia, By Hypertriglyceridemia, Dyslipidaemia, Others), By Company, By Region, Forecast & Opportunities, FY2026

High prevalence of cardiovascular diseases is expected to drive the growth of India atorvastatin market.Read More

India Acyclovir Market By Source (In-house v/s Contract Manufacturing Organizations), By Form (Tablet, Capsule, Ointment/Cream, Injection, Powder for Solution, Others), By Route of Administration (Oral, Injectable, Topical, Others), By Type of Virus (Herpes Simplex Virus Type I (HSV-1), Herpes Simplex Virus Type II (HSV-2), Varicella Zoster Virus (VZV), Epstein-Barr Virus (EBV), Cytomegalovirus (CMV)), By Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Others), By Distribution Channel (Online v/s Offline), By Application (Cold Soares, Chickenpox, Genital Herpes, Shingles, Hepatitis, HIV, Influenza, Others), By End User (Children up to 12 years v/s Adults), By Company, By Region, Forecast & Opportunities, FY2026

Growing prevalence of viral diseases is expected to drive the growth of India acyclovir market.Read More

Prev    Page 22 of 23 Next